Keurig Dr Pepper (KDP)
(Delayed Data from NSDQ)
$37.02 USD
-0.17 (-0.46%)
Updated Oct 2, 2024 04:00 PM ET
After-Market: $36.99 -0.03 (-0.08%) 5:56 PM ET
4-Sell of 5 4
D Value D Growth B Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$37.02 USD
-0.17 (-0.46%)
Updated Oct 2, 2024 04:00 PM ET
After-Market: $36.99 -0.03 (-0.08%) 5:56 PM ET
4-Sell of 5 4
D Value D Growth B Momentum D VGM
Zacks News
Earnings Preview: Keurig Dr Pepper (KDP) Q4 Earnings Expected to Decline
by Zacks Equity Research
Keurig Dr Pepper (KDP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
The Zacks Analyst Blog Highlights: Morgan Stanley, Intuitive Surgical, Colgate-Palmolive, Keurig Dr Pepper and Prudential Financial
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Morgan Stanley, Intuitive Surgical, Colgate-Palmolive, Keurig Dr Pepper and Prudential Financial
Top Research Reports for Morgan Stanley, Intuitive Surgical & Colgate-Palmolive
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, Morgan Stanley (MS), Intuitive Surgical, Inc. (ISRG) and Colgate-Palmolive Company (CL).
Will P&G's (PG) Efforts Help Sustain Stock Momentum in 2019?
by Zacks Equity Research
Procter & Gamble (PG) displays momentum, backed by impressive growth strategies and cost-saving efforts to boost margins, which have boosted its top and bottom lines.
Will Monster Beverage's Strategies Cushion the Stock in 2019?
by Zacks Equity Research
Monster Beverage (MNST) witnesses strained margins, owing to higher expenses. However, its solid energy drink category and other efforts are encouraging.
Molson Coors (TAP) Shows Resilience: Stock to Surge in 2019?
by Zacks Equity Research
Molson Coors (TAP) displays momentum backed by focus on cost savings and premiumization of its portfolio, which has boosted its top and bottom lines.
Here's Why You Should Hold on to Keurig Dr Pepper Stock Now
by Zacks Equity Research
Keurig Dr Pepper's (KDP) strong performance in third-quarter 2018 and a promising outlook, alongside its partnerships and acquisition strategy, position it for growth in the future.
Why Is Keurig Dr Pepper (KDP) Down 8.8% Since Last Earnings Report?
by Zacks Equity Research
Keurig Dr Pepper (KDP) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks.com featured highlights include: Twitter, Lockheed Martin, Intercontinental Exchange, CBRE and Keurig Dr Pepper
by Zacks Equity Research
Zacks.com featured highlights include: Twitter, Lockheed Martin, Intercontinental Exchange, CBRE and Keurig Dr Pepper
The Zacks Analyst Blog Highlights: PetroChina, NextEra, Eni, Dr Pepper and Regeneron
by Zacks Equity Research
The Zacks Analyst Blog Highlights: PetroChina, NextEra, Eni, Dr Pepper and Regeneron
Buy These 5 Stocks With Sales Growth Amid Volatile Markets
by Zacks Equity Research
A company can improve earnings by controlling costs and maintaining stable revenues. But superior profits can only be generated through steady sales growth.
Top Stock Reports for PetroChina, NextEra & Eni
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including PetroChina (PTR), NextEra (NEE) and Eni (E).
Time to Buy Coca-Cola (KO) Stock Near New All-Time High?
by Benjamin Rains
Should investors consider buying Coca-Cola stock with its shares up 11% over the last month alone?
Keurig Dr Pepper (KDP) Beats on Q3 Earnings, Retains View
by Zacks Equity Research
Keurig Dr Pepper's (KDP) reports third-quarter 2018 results, wherein earnings beat estimates and sales lag. The company remains optimistic about its long-term growth targets.
Can Keurig Dr Pepper (KDP) Deliver Earnings Beat in Q3?
by Zacks Equity Research
Keurig Dr Pepper (KDP) is poised to gain from DPS' distribution strategy and innovation alongside Keurig's coffee brands and online presence. But, soft CSD trends and higher aluminum prices are woes.
Earnings Preview: Keurig Dr Pepper (KDP) Q3 Earnings Expected to Decline
by Zacks Equity Research
Keurig Dr Pepper (KDP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Coca-Cola (KO) Tops Q3 Earnings & Revenues, Retains View
by Zacks Equity Research
Solid growth strategies and productivity efforts aid Coca-Cola's (KO) earnings and sales in third-quarter 2018.
The Zacks Analyst Blog Highlights: PayPal, Schlumberger, Blackstone, V.F. and Keurig
by Zacks Equity Research
The Zacks Analyst Blog Highlights: PayPal, Schlumberger, Blackstone, V.F. and Keurig
Top Stock Reports for PayPal, Schlumberger & Blackstone
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including PayPal (PYPL), Schlumberger (SLB) and Blackstone (BX).
Keurig Dr Pepper (KDP) Q3 Earnings Preview: What's in the Cards?
by Zacks Equity Research
Keurig Dr Pepper (KDP) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Molson Coors and HEXO Joint Venture Goes Live as "Truss"
by Zacks Equity Research
Molson Coors Canada (TAP) and Hydropothecary launch its JV, Truss, to explore the non-alcoholic cannabis-infused drinks market, just before cannabis trade is legalized in Canada.
PepsiCo (PEP) Q3 Earnings & Sales Top, Organic Sales View Up
by Zacks Equity Research
PepsiCo (PEP) delivers top and bottom line beat in third-quarter 2018 on strong performance in international division, alongside sequential revenue growth in NAB segment.
Keurig Dr Pepper (KDP) to Acquire CORE Nutrition for $525M
by Zacks Equity Research
Keurig Dr Pepper (KDP) signs an agreement to acquire CORE Nutrition LLC - a leading bottled water and other drinks' maker - for $525 million.
PepsiCo Holds Ground Despite Tough Conditions, Stock Gains 9%
by Zacks Equity Research
PepsiCO (PEP) rallies despite industry headwinds, including a shift to healthier drinks and higher costs. The company's snacking portfolio and innovation pipeline shows potential for further growth.
Keurig Dr Pepper (KDP) Down 3.7% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Keurig Dr Pepper (KDP) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.